Precision Biosciences, Inc. · NASDAQ:DTIL

Matthew Smith reported a 8.90% stake in Precision Biosciences, Inc. (Schedule 13G)

Event Mar 19, 2025 · Filed Mar 26, 2025

Matthew Smith reported a 8.90% stake in Precision Biosciences, Inc., 932,874 shares, as a passive investor on Mar 19, 2025. Filed Mar 26, 2025 (Schedule 13G).

Stake
8.90%
Shares
932,874
Intent
Passive
What changed
Crossed above 5%
Filed together
5 holders

The filing in full

HolderStakeShares
Readout Capital, LP8.80%920,000
Readout Capital GP, LLC8.80%920,000
ROC Holdings SPV II, LP6.90%720,000
Readout Holdings GP, LLC6.90%720,000
Matthew Smith8.90%932,874

Source

View original at SEC

Related